Condition
Colorectal Cancer (Locally Advanced or Metastatic) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Colorectal Cancer (Locally Advanced or Metastatic) clinical trials that are recruiting, at sites in 3 countries (most in China (1), Moldova (1), United States (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
SOT109 in advanced colorectal cancer: a two-part study to find safe doses and see if it helps
This study tests SOT109 in adults with unresectable or metastatic colorectal cancer to find safe dose levels and see if the drug can help those who have few options left.
-
Biomarker-guided donor CAR-NK therapy targeting one or two tumor antigens for advanced solid tumors
This treatment tries donor-derived CAR-NK cells that target one or two tumor antigens for adults with advanced solid tumors such as breast, NSCLC, colorectal, and recurrent prostate cancer.
Related topics
Quick answers
How many Colorectal Cancer (Locally Advanced or Metastatic) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (1 trial), Moldova (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.